Picture of Amedisys logo

AMED Amedisys Income Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedMid CapNeutral

Annual income statement for Amedisys, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue1,9562,0722,2142,2232,236
Cost of Revenue
Gross Profit8058861,015972991
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses1,7781,8521,9622,0422,186
Operating Profit17721925218150.4
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes17021128016039.6
Provision for Income Taxes
Net Income After Taxes128185210118-10.9
Minority Interest
Net Income Before Extraordinary Items
Net Income127184209119-9.75
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income127184209119-9.75
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS4.275.056.843.962.55